{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T05:02:24Z","timestamp":1783227744067,"version":"3.54.6"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Health Serv."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Various intravenous iron formulations show great promise in the treatment of iron deficiency anemia (IDA), and economic evaluation results are becoming increasingly important as criteria for allocating healthcare resources. This study aimed to systematically evaluate the economics of six main intravenous iron formulations in the treatment of IDA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Computerized search of relevant studies in PubMed, Embase, Web of Science, and The Cochrane Library to collect economic evaluation of six intravenous iron formulations for the treatment of patients with IDA; the time limit for searching was from the establishment of the database to 30 July 2025. Two reviewers independently screened literature, extracted data, evaluated the quality of included studies using the Consolidated Health Economic Evaluations Reporting Standards 2022, and performed descriptive analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 2,288 articles retrieved, 17 studies were included, including five drugs, conducted in 10 different countries. Six studies compared ferric carboxymaltose (FCM) with iron sucrose (IS); two studies compared FCM, ferric derisomaltose (FDI), and IS; one study compared FCM, iron dextran (ID), and IS; one study compared FCM, IS, ID, and FDI at three dose levels; one study obtained an economic ranking for FCM, ID, IS, and ferrous gluconate (FG); five studies compared FDI and FCM; and one study compared FDI with IS. The overall quality of the included studies was high. A total of 13 studies conducted sensitivity analyses to check the robustness of their results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review systematically evaluates the economic characteristics of the six main intravenous iron formulations for treating IDA. Current evidence suggests that the efficacy of FDI is better than IS, and the economic ranking of the four intravenous iron formulations can be summarized as FCM, ID, IS, and FG. Further research is needed to justify the economic comparison between FCM and FDI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/frhs.2025.1690519","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:37:25Z","timestamp":1763534245000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Economic evaluation of intravenous iron formulations for patients with iron deficiency anemia: a systematic review"],"prefix":"10.3389","volume":"5","author":[{"given":"Zhicong","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fudong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guige","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"B1","article-title":"Anemia","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"e713","DOI":"10.1016\/s2352-3026(23)00160-6","article-title":"Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990\u20132021: findings from the global burden of disease study 2021","volume":"10","author":"Gardner","year":"2023","journal-title":"Lancet Haematol"},{"key":"B3","article-title":"Iron Deficiency Anemia Treatment Market Size, Growth, Trends, Forecast 2021\u20132030","year":"2022"},{"key":"B4","article-title":"Iron Deficiency Anemia Market - Global Industry Size, Share, Trends Oppor, Forecast 2018\u20132028","author":"Markets","year":"2023"},{"key":"B5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000503707","article-title":"Consensus statement by an expert panel on the diagnosis and management of iron deficiency anemia in the Gulf Cooperation Council countries","volume":"29","author":"Aleem","year":"2020","journal-title":"Med Princ Pract"},{"key":"B6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4274\/tjod.01700","article-title":"Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period: iron deficiency anemia working group consensus report","volume":"12","author":"Api","year":"2015","journal-title":"Turk J Obstet Gynecol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1080\/03007995.2020.1824898","article-title":"Systematic review of guidelines for the diagnosis and treatment of iron deficiency anemia using intravenous iron across multiple indications","volume":"36","author":"Numan","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.3760\/cma.j.cn112137-20220621-0136110.3760\/cma","article-title":"Multidisciplinary expert consensus on the diagnosis, treatment and prevention of iron deficiency and iron deficiency anemia (2022 edition)","volume":"102","year":"2022","journal-title":"Chin Med J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3760\/cma.j.cn112139-20200210-00073n","article-title":"Multidisciplinary expert\u2019s consensus on the management of perioperative iron deficiency anemia in patients accepting general surgery","volume":"58","year":"2020","journal-title":"Chin J Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","article-title":"Anemia of inflammation","volume":"133","author":"Weiss","year":"2019","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/joim.13004","article-title":"Iron deficiency anaemia revisited","volume":"287","author":"Cappellini","year":"2019","journal-title":"J Intern Med"},{"key":"B12","article-title":"WHO calls for accelerated action to reduce anaemia","year":"2023"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.13276\/j.issn.2097-1656.2023.12.015","article-title":"Research progress of drugs for iron deficiency anemia","volume":"44","author":"Yuying","year":"2023","journal-title":"J Air Force Mil Med Univ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"100862","DOI":"10.1016\/j.mam.2020.100862","article-title":"Intravenous iron supplementation therapy","volume":"75","author":"Schaefer","year":"2020","journal-title":"Mol Aspects Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.3324\/haematol.2024.284967","article-title":"Oral iron supplementation: new formulations, old questions","volume":"109","author":"Pantopoulos","year":"2024","journal-title":"Haematologica"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/ajh.27220","article-title":"Expert consensus guidelines: intravenous iron uses, formulations, administration, and management of reactions","volume":"99","author":"Doren","year":"2024","journal-title":"Am J Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.1016\/S2352-3026(21)00137-X","article-title":"Iron (Fe) preparations for women of reproductive age with iron deficiency anaemia in pregnancy: FRIDA, a systematic review and network meta-analysis","volume":"8","author":"Rogozi\u0144ska","year":"2022","journal-title":"Lancet Haematol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3760\/cma.j.issn.0253-2727.2019.05.002","article-title":"Chinese expert consensus on the application of intravenous iron (2019)","volume":"40","year":"2019","journal-title":"Chin J Hematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ijgo.14804","article-title":"Expert consensus on improving iron deficiency anemia management in obstetrics and gynecology in Asia","volume":"163","author":"Leung","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/sla.0000000000005721","article-title":"Recommendations from the international consensus conference on anemia management in surgical patients (ICCAMS)","volume":"277","author":"Shander","year":"2023","journal-title":"Ann Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1136\/gutjnl-2021-325210","article-title":"British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults","volume":"70","author":"Snook","year":"2021","journal-title":"Gut"},{"key":"B22","article-title":"Guideline for the management of anaemia in the perioperative pathway","year":"2022"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e000759","DOI":"10.1136\/bmjgast-2021-000759","article-title":"Iron deficiency anaemia: pathophysiology, assessment, practical management","volume":"9","author":"Kumar","year":"2022","journal-title":"BMJ Open Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1756283X11398736","article-title":"Diagnosis and management of iron deficiency anemia in the 21st century","volume":"4","author":"Johnson-Wimbley","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.13286\/j.1001-5213.2022.23.22","article-title":"Progress in clinical application of drugs to the treatment of iron deficiency anemia","volume":"42","author":"Ying","year":"2022","journal-title":"Chin J Hosp Pharm"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/ajh.25995","article-title":"A multicenter study evaluating the effectiveness and safety of single-dose low molecular weight iron dextran vs single-dose ferumoxytol for the treatment of iron deficiency","volume":"95","author":"Cohen","year":"2020","journal-title":"Am J Hematol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2302773","DOI":"10.1002\/adhm.202302773","article-title":"The story of ferumoxytol: synthesis production, current clinical applications, and therapeutic potential","volume":"13","author":"Long","year":"2024","journal-title":"Adv Healthcare Mater"},{"key":"B28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2165\/00003495-200969060-00007","article-title":"Ferric carboxymaltose: a review of its use in iron-deficiency anaemia","volume":"69","author":"Katherine","year":"2009","journal-title":"Drugs"},{"key":"B29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40264-020-01022-2","article-title":"Frequency and associated costs of anaphylaxis- and hypersensitivity-related adverse events for intravenous iron products in the USA: an analysis using the US Food and Drug Administration adverse event reporting system","volume":"44","author":"Trumbo","year":"2021","journal-title":"Drug Saf"},{"key":"B30","doi-asserted-by":"publisher","first-page":"20410","DOI":"10.1038\/s41598-019-56999-3","article-title":"Ferric carboxymaltose in the treatment of chemotherapy-induced anaemia: an effective, safe and cost-sparing alternative to blood transfusion","volume":"9","author":"Marinho","year":"2019","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3111\/13696998.2011.639823","article-title":"Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoiesis-stimulating agents and blood transfusion: French healthcare payer perspective","volume":"15","author":"Luporsi","year":"2012","journal-title":"J Med Econ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1478-7547-12-19","article-title":"Cost-utility of ferric carboxymaltose (Ferinject\u00ae) for iron-deficiency anemia patients with chronic heart failure in South Korea","volume":"12","author":"Lim","year":"2014","journal-title":"Cost Eff Resour Alloc"},{"key":"B33","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"key":"B35","doi-asserted-by":"publisher","first-page":"106820","DOI":"10.1016\/j.ijsu.2022.106820","article-title":"Economic evaluation of laboratory diagnostic test types in COVID-19 epidemic: a systematic review","volume":"105","author":"Dolatshahi","year":"2022","journal-title":"Int J Surg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2147\/CEOR.S306823","article-title":"Evaluation of the cost-effectiveness of iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease in the UK","volume":"13","author":"Aksan","year":"2021","journal-title":"Clinicoecon Outcomes Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s12325-020-01553-1","article-title":"Iron formulations for the treatment of iron deficiency anemia in patients with inflammatory bowel disease: a cost-effectiveness analysis in Switzerland","volume":"38","author":"Aksan","year":"2020","journal-title":"Adv Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17562848221086131","article-title":"Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain","volume":"15","author":"Arg\u00fcelles-Arias","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0255104","DOI":"10.1371\/journal.pone.0255104","article-title":"Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia","volume":"16","author":"Basha","year":"2021","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/13696998.2020.1745535","article-title":"A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom","volume":"27","author":"Pollock","year":"2020","journal-title":"J Med Econ"},{"key":"B41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000330738","article-title":"Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia","volume":"81","author":"Szucs","year":"2011","journal-title":"Oncology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/13696998.2022.2065092","article-title":"Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose","volume":"25","author":"Hu","year":"2022","journal-title":"J Med Econ"},{"key":"B43","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/13696998.2024.2313932","article-title":"Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England","volume":"27","author":"Iqbal","year":"2024","journal-title":"J Med Econ"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1007\/s12325-024-02987-7","article-title":"A cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with iron deficiency anemia in China","volume":"41","author":"Zhang","year":"2024","journal-title":"Adv Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/13696998.2025.2487359","article-title":"A Swedish cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in the treatment of iron deficiency anemia in patients with inflammatory bowel disease","volume":"28","author":"Lindgren","year":"2025","journal-title":"J Med Econ"},{"key":"B46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/13696998.2024.2444833","article-title":"Evaluating the cost-utility of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in Norway","volume":"28","author":"Detlie","year":"2025","journal-title":"J Med Econ"},{"key":"B47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4103\/joah.joah_64_23","article-title":"Cost-minimization analysis in iron-deficiency anemia comparing intravenous ferric carboxymaltose to standard of care in pregnant women in Algeria","volume":"14","author":"Aladham","year":"2023","journal-title":"J Appl Hematol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/THC-151074","article-title":"Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia","volume":"24","author":"Calvet","year":"2016","journal-title":"Technol Health Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e45604","DOI":"10.1371\/journal.pone.0045604","article-title":"Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency","volume":"7","author":"Calvet","year":"2012","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/CEOR.S30514","article-title":"Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece","volume":"4","author":"Fragoulakis","year":"2012","journal-title":"Clinicoecon Outcomes Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2147\/TCRM.S25882","article-title":"Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice","volume":"7","author":"Bhandari","year":"2011","journal-title":"Ther Clin Risk Manage"},{"key":"B52","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.crohns.2010.01.007","article-title":"The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective","volume":"4","author":"Bager","year":"2010","journal-title":"J Crohns Colitis"},{"key":"B53","article-title":"China Guidelines for Pharmacoeconomic Evaluations","year":"2019"},{"key":"B54","article-title":"Developing NICE guidelines: the manual: 7 Incorporating economic evaluation","year":"2024"},{"key":"B55","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomaltoside vs. ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"}],"container-title":["Frontiers in Health Services"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2025.1690519\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:37:29Z","timestamp":1763534249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2025.1690519\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":55,"alternative-id":["10.3389\/frhs.2025.1690519"],"URL":"https:\/\/doi.org\/10.3389\/frhs.2025.1690519","relation":{},"ISSN":["2813-0146"],"issn-type":[{"value":"2813-0146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"article-number":"1690519"}}